Filing Details

Accession Number:
0001140361-17-046572
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-12-18 17:40:28
Reporting Period:
2017-12-14
Accepted Time:
2017-12-18 17:40:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1581720 Loxo Oncology Inc. LOXO Pharmaceutical Preparations (2834) 462996673
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1612312 H. Joshua Bilenker C/O Loxo Oncology, Inc.
281 Tresser Boulevard, 9Th Floor
Stamford CT 06901
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-12-14 7,500 $1.18 190,207 No 4 M Direct
Common Stock Disposition 2017-12-14 2,600 $82.55 187,607 No 4 S Direct
Common Stock Disposition 2017-12-14 2,900 $83.42 184,707 No 4 S Direct
Common Stock Disposition 2017-12-14 2,000 $84.29 182,707 No 4 S Direct
Common Stock Acquisiton 2017-12-15 7,500 $1.18 190,207 No 4 M Direct
Common Stock Disposition 2017-12-15 700 $76.93 189,507 No 4 S Direct
Common Stock Disposition 2017-12-15 2,268 $78.06 187,239 No 4 S Direct
Common Stock Disposition 2017-12-15 3,023 $78.99 184,216 No 4 S Direct
Common Stock Disposition 2017-12-15 609 $80.08 183,607 No 4 S Direct
Common Stock Disposition 2017-12-15 600 $80.88 183,007 No 4 S Direct
Common Stock Disposition 2017-12-15 100 $81.72 182,907 No 4 S Direct
Common Stock Disposition 2017-12-15 200 $82.86 182,707 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2017-12-14 7,500 $0.00 7,500 $1.18
Common Stock Employee Stock Option (right to buy) Disposition 2017-12-15 7,500 $0.00 7,500 $1.18
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
97,190 2023-11-14 No 4 M Direct
89,690 2023-11-14 No 4 M Direct
Footnotes
  1. The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
  2. Represents the aggregate of sales effected on the same day at different prices.
  3. Represents the weighted average sales price per share. The shares sold at prices ranging from $81.96 to $82.94 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
  4. Represents the weighted average sales price per share. The shares sold at prices ranging from $82.96 to $83.94 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
  5. Represents the weighted average sales price per share. The shares sold at prices ranging from $83.99 to $84.74 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
  6. Represents the weighted average sales price per share. The shares sold at prices ranging from $76.43 to $77.31 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
  7. Represents the weighted average sales price per share. The shares sold at prices ranging from $77.51 to $78.49 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
  8. Represents the weighted average sales price per share. The shares sold at prices ranging from $78.57 to $79.38 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
  9. Represents the weighted average sales price per share. The shares sold at prices ranging from $79.63 to $80.50 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
  10. Represents the weighted average sales price per share. The shares sold at prices ranging from $80.67 to $81.16 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
  11. The stock option is immediately exercisable in full, and vests as to 25% of the shares subject to the option on the one-year anniversary of the vesting commencement date, and thereafter as to 1/48th of the shares in equal monthly installments.